Holly Bode Appointed Vice President of Government Affairs by American Kidney Fund
FOR IMMEDIATE RELEASE
ROCKVILLE, Maryland (January 27, 2017)—The American Kidney Fund (AKF), the nation’s leading nonprofit working on behalf of the 31 million Americans with kidney disease, today announced that Holly Bode has joined the organization as Vice President of Government Affairs. In this position, she will lead AKF’s advocacy efforts on behalf of people living with kidney disease.
Bode has worked on health issues in Washington—on both the political and policy fronts—for over 30 years. She comes to AKF from the Alliance of Community Health Plans (ACHP), where she led federal lobbying and communications efforts for nearly five years.
“Holly’s deep understanding of the health care landscape and the policies that shape it will be a great asset in our ongoing efforts to make sure that the voice of kidney patients is heard by legislators and regulators at the federal and state levels,” said LaVarne A. Burton, president and chief executive officer of the American Kidney Fund.
Prior to ACHP, Bode worked at Washington Council Ernst & Young, where she provided strategic political and policy counsel to a variety of health care and employer clients, with a focus on the implementation of the Affordable Care Act. Before that, she was with UnitedHealth Group where she coordinated the federal affairs strategy for United’s Medicare and Medicaid products. She also worked for various members of the U.S. Senate and House of Representatives as well as at the U.S. Department of Health and Human Services.
About the American Kidney Fund
As the nation’s leading nonprofit working on behalf of the 31 million Americans with kidney disease, the American Kidney Fund is dedicated to ensuring that every kidney patient has access to health care, and that every person at risk for kidney disease is empowered to prevent it. AKF provides a complete spectrum of programs and services: prevention outreach, top-rated health educational resources, and direct financial assistance enabling 1 in 5 U.S. dialysis patients to access lifesaving medical care, including dialysis and transplantation.